Serial Number 88573199
Registration 6725270
700

Registration Progress

Application Filed
Aug 9, 2019
Under Examination
Sep 1, 2020
Approved for Publication
Jul 7, 2020
Published for Opposition
Jul 7, 2020
Registered
May 24, 2022

Trademark Image

Basic Information

Serial Number
88573199
Registration Number
6725270
Filing Date
August 9, 2019
Registration Date
May 24, 2022
Published for Opposition
July 7, 2020
Drawing Code
2000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 24, 2022
Registration
Registered
Classes
005

Rights Holder

Bioverativ Therapeutics Inc.

03
Address
225 Second Avenue
Waltham, MA 02451

Ownership History

Bioverativ Therapeutics Inc.

Original Applicant
03
Waltham, MA

Bioverativ Therapeutics Inc.

Owner at Publication
03
Waltham, MA

Bioverativ Therapeutics Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
1039 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-05-24)
Due Date
May 24, 2028
Grace Period Ends
November 24, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
May 24, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 24, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 2, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 1, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 23, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 23, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 25, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 25, 2022 IUAF S USE AMENDMENT FILED Loading...
Aug 5, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 3, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 3, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 3, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 1, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 7, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 7, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 17, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 29, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 8, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 7, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 7, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 8, 2020 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Dec 10, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 8, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 8, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 8, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 7, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 27, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 26, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 13, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for treating cold agglutinin disease
First Use Anywhere: Feb 21, 2022
First Use in Commerce: Feb 21, 2022

Additional Information

Design Mark
The mark consists of five aligned rectangles forming a curved band in the colors light pink, orange, light blue, that curves upward on the right side, and also on the left side, but with the translucent rectangles in the colors dark blue and medium blue folding over to create a triangle shape in the middle in the band.
Color Claim
The color(s) light pink, orange, light blue, dark blue, and medium blue is/are claimed as a feature of the mark.

Classification

International Classes
005